Dog Degenerative Myelopathy: Welfare and End-of-Life Care

Degenerative myelopathy is a progressive, fatal neurological disease in dogs requiring compassionate welfare management through progressive disability.

Key Facts

DM is most common in German Shepherds, Pembroke Welsh Corgis, and Boxers but affects many breeds
A mutation in the SOD1 gene is strongly associated with DM risk in most affected breeds
The condition progresses from mild hindlimb ataxia to complete paraplegia and eventually forelimb involvement
DNA testing identifies at-risk dogs before clinical signs develop, enabling breeding decisions
There is no treatment to halt progression but physical rehabilitation slows functional decline

Welfare Considerations

Dogs with DM experience progressive loss of hindlimb function over 6-18 months before complete paralysis and eventually respiratory muscle involvement. The dog's cognitive function and comfort are maintained throughout most of the disease, meaning welfare management focuses on maintaining mobility, preventing pressure sores, managing incontinence, and preserving social engagement. Physical rehabilitation slows progression and maintains muscle mass and mobility longer than rest alone. Wheels and carts provide mobility options extending quality of life. End-of-life decisions are complex because dogs often remain cognitively intact and engaged with their family even as physical function fails completely. Quality-of-life assessment frameworks guide humane timing of euthanasia.

What You Can Do

Test at-risk breeds for the SOD1 mutation before breeding to reduce DM prevalence
Begin physical rehabilitation early at first signs of DM to maximize functional longevity
Invest in a well-fitted wheelchair to maintain mobility and engagement as hindlimb function declines
Use quality-of-life assessment tools regularly to guide end-of-life decisions with your veterinarian